Diabetic Nephropathy Market Set to Reach USD 3.97 Billion by 2032, Fueled by Rising Type-2 Diabetes Prevalence and Breakthroughs in SGLT2 Inhibitor Therapy – SNS Insider
SNS Insider Reveals Strategic Outlook on the U.S. Diabetic Nephropathy Market, Valued at USD 0.79 Billion in 2024, Commanding the…